Change search
ReferencesLink to record
Permanent link

Direct link
Paclitaxel-carboplatin-gemcitabine (TCG) as first-line treatment of ovarian cancer: a prospective multicenter phase II study (AGO-OVAR 8) followed by a prospectively randomized phase III GCIG intergroup study (AGO-OVAR 9, GINECO-TCG, NSGO-OC-0102) comparing TCG with standard TC
Show others and affiliations
2005 (English)In: Int J Gynecol Cancer: Supplement 3, Vol. 15, 224-225 p.Article in journal (Refereed) Published
Place, publisher, year, edition, pages
2005. Vol. 15, 224-225 p.
URN: urn:nbn:se:umu:diva-14321OAI: diva2:153992
Available from: 2007-02-23 Created: 2007-02-23 Last updated: 2011-01-12Bibliographically approved

Open Access in DiVA

No full text

Search in DiVA

By author/editor
Boman, Karin
By organisation

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Total: 36 hits
ReferencesLink to record
Permanent link

Direct link